Guide (Latest 2025/2026 Update) – Verified Q&A & Rationales
Master the most challenging nursing assessment with this comprehensive ATI
Pharmacology 2026 prep guide featuring 250 verified practice questions and in-depth
rationales. This guide focuses on high-yield medication classes, including
cardiovascular, psychotropic, and anti-infective agents, along with critical safety
protocols and "must-know" side effects. Fully updated for the 2025/2026 cycle, it is the
ultimate tool for students facing a retake or aiming for a Level 3 proficiency on their first
attempt.
Section 1: Pharmacokinetics & Foundations
A patient with end-stage renal disease (ESRD) requires a medication primarily
cleared by the kidneys. How should the nurse practitioner adjust the
regimen?
A) Increase the dose frequency.
B) Decrease the dose or increase the dosing interval.
C) Switch to an oral route to slow absorption.
D) No adjustment is needed if the patient is on dialysis.
Rationale: Impaired renal clearance leads to drug accumulation and
toxicity; reducing the dose or extending the time between doses is
mandatory.
Which term describes the percentage of an administered drug that reaches the
systemic circulation in an unchanged form?
A) Half-life.
B) Bioavailability.
C) First-pass effect.
D) Volume of distribution.
Rationale: Bioavailability is 100% for IV drugs but varies for oral
medications due to absorption and liver metabolism.
In the elderly, a decrease in serum albumin levels most significantly affects
the pharmacokinetics of:
, A) Lipophilic drugs.
B) Highly protein-bound drugs (e.g., Warfarin, Phenytoin).
C) Water-soluble drugs.
D) Prodrugs.
Rationale: Less albumin means more "free" (active) drug in the
bloodstream, increasing the risk of toxicity.
What is the primary site of the "First-Pass Effect"?
A) Small Intestine.
B) Liver.
C) Kidneys.
D) Stomach.
Rationale: Drugs absorbed in the GI tract travel via the portal vein to the
liver, where significant metabolism occurs before reaching the heart.
A "Prodrug" is a medication that:
A) Is excreted unchanged by the kidneys.
B) Is inactive until it is metabolized by the liver.
C) Has a very short half-life.
D) Binds irreversibly to its receptor.
Rationale: Prodrugs (like Enalapril or Codeine) require hepatic enzymes
to convert them into their active pharmacological forms.
Section 2: Autonomic Nervous System (ANS)
A patient is experiencing a "Cholinergic Crisis" (overdose of Acetylcholine).
Which medication is the antidote?
A) Bethanechol.
B) Atropine.
C) Epinephrine.
D) Propranolol.
Rationale: Atropine is an anticholinergic that blocks muscarinic
receptors to reverse "wet" symptoms (salivation, tearing,
bradycardia).
A patient with BPH is prescribed Tamsulosin (Flomax). What is the mechanism of
action?
A) Beta-2 agonist.
B) Alpha-1 antagonist.
C) Muscarinic agonist.
, D) 5-alpha reductase inhibitor.
Rationale: Alpha-1 blockers relax the smooth muscle of the bladder
neck and prostate to improve urine flow.
Non-selective Beta-blockers (like Propranolol) should be used with extreme
caution in patients with:
A) Hypertension.
B) Asthma/COPD.
C) Hyperthyroidism.
D) Tachycardia.
Rationale: Blocking Beta-2 receptors in the lungs can lead to life-
threatening bronchoconstriction.
Which neurotransmitter is primarily responsible for the "Fight or Flight"
sympathetic response?
A) Acetylcholine.
B) Norepinephrine.
C) Serotonin.
D) GABA.
Rationale: Norepinephrine and Epinephrine act on alpha and beta
receptors to increase HR and BP.
A patient is given a drug that stimulates the Parasympathetic Nervous System.
What is an expected finding?
A) Tachycardia.
B) Mydriasis (dilated pupils).
C) Increased GI motility.
D) Bronchodilation.
Rationale: "Rest and Digest" increases secretions and peristalsis while
slowing the heart rate.
Section 3: Cardiovascular Pharmacology
What is the most common side effect associated with Dihydropyridine Calcium
Channel Blockers (e.g., Amlodipine)?
A) Dry cough.
B) Peripheral edema.
C) Hyperkalemia.
D) Lupus-like syndrome.
, Rationale: CCBs cause potent vasodilation, which often leads to fluid
pooling in the lower extremities.
Which class of drugs is the first-line treatment for Heart Failure with Reduced
Ejection Fraction (HFrEF) because they prevent cardiac remodeling?
A) Loop Diuretics.
B) ACE Inhibitors (or ARBs).
C) Digoxin.
D) Calcium Channel Blockers.
Rationale: ACEIs inhibit the RAAS system, which is crucial for
preventing the structural worsening of the heart.
A patient taking Digoxin reports seeing "yellow-green halos" and has nausea.
What is the immediate priority?
A) Increase potassium intake.
B) Assess serum Digoxin and Potassium levels.
C) Double the next dose.
D) Administer a beta-blocker.
Rationale: These are classic signs of Digoxin toxicity, often exacerbated
by hypokalemia.
What is the "Black Box Warning" for most Beta-blockers?
A) Risk of sudden blindness.
B) Risk of rebound hypertension or MI if discontinued abruptly.
C) Risk of tendon rupture.
D) Risk of severe diarrhea.
Rationale: Receptors become "upregulated" during blockage; sudden
stopping leads to sympathetic over-stimulation.
Which medication is the preferred treatment for an African American patient with
hypertension and no other comorbidities?
A) Lisinopril.
B) Chlorthalidone (Thiazide) or Amlodipine (CCB).
C) Losartan.
D) Metoprolol.
Rationale: Clinical trials (ALLHAT) show African American patients
respond better to Thiazides and CCBs than ACEIs as monotherapy.
Section 4: Psychiatric & Neurological Pharmacology
SSRIs (e.g., Fluoxetine) are preferred over TCAs primarily because: